Nephrologist are often faced with the question of the appropriate initiation and withdrawal from dialysis. Many clinicians feel that patient should be offered dialysis when they have ESRD regardless of the potential risks vs. benefits. My position in this debate is that nephrologists have the obligation to order treatments that are indicated and effective for their patients and will provide more benefit that harm. They should not order dialysis in patient that are not likely to benefit from the treatment. Patients have the right to refuse treatments but not the right to demand that a clinician order an ineffective treatment. Shared decision making is the key principle in deciding on the initiation and withdrawal from dialysis. The national guideline; Shared Decision Making: The Appropriate Initiation and Withdrawal from Dialysis supports this approach.

Keywords:
Dialysis, Elderly, Withdrawal, Conservative care, Palliative care, Ethics
1.
Renal Physicians Association: Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis, ed 2. Rockville, Maryland, 2010.
2.
Quill TE, Holloway R: Time-limited trials near the end of life. JAMA 2011;306:1483-1484.
3.
Rosansky SJ: Early dialysis initiation, a look from the rearview mirror to what's ahead. Clin J Am Soc Nephrol 2014;9:222-224.
4.
Slinin Y, Guo H, Li S, Liu J, Morgan B, Ensrud K, Gilbertson DT, Collins AJ, Ishani A: Provider and care characteristics associated with timing of dialysis initiation. Clin J Am Soc Nephrol 2014;9:310-317.
5.
Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA; for the IDEAL Study: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010;363:606-619.
6.
Rosansky SJ, Eggers P, Jackson K, Glassock R, Clark WF: Early start of hemodialysis may be harmful. Arch Intern Med 2011;171:396-403.
7.
Schell JO, Da Silva-Gane M, Germain MJ: Recent insights into life expectancy with and without dialysis. Curr Opin Nephrol Hypertens 2013;22:185-192.
8.
O'Connor NR, Kumar P: Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 2012;15:228-235.
9.
Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955-1962.
10.
Carson RC, Juszczak M, Davenport A, Burns A: Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 2009;4:1611-1619.
11.
Da Silva-Gane M, Wellsted D, Greenshields H, Norton S, Chandna SM, Farrington K: Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol 2012;7:2002-2009.
12.
Eloot S, Schepers E, Barreto DV, Barreto FC, Liabeuf S, Van Biesen W, et al: Estimated glomerular filtration rate is a poor predictor of concentration for a broad range of uremic toxins. Clin J Am Soc Nephrol 2011;6:1266-1273.
13.
Fontseré N, Bonal J, Navarro M, et al: A comparison of prediction equations for estimating glomerular filtration rate in adult patients with chronic kidney disease stages 4-5. Effect of nutritional status and age. Nephron Clin Pract 2006;104:c160-c168.
15.
Moss AH: Ethical principles and processes guiding dialysis decision-making. Clin J Am Soc Nephrol 2011;6:2313-2317.
16.
Davison SN: The ethics of end-of-life care for patients with ESRD. Clin J Am Soc Nephrol 2012;7:2049-2057.
17.
Skold A, Lesandrini J, Gorbatkin S: Ethics and health policy of dialyzing a patient in a persistent vegetative state. Clin J Am Soc Nephrol 2014;9:366-370.
18.
Akbar S, Moss AH: The ethics of offering dialysis for AKI to the older patient: time to re-evaluate? Clin J Am Soc Nephrol 2014;9:1652-1656.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.